REDUCTION OF PRESSOR EFFECTS OF ANGIOTENSIN I IN MAN BY SYNTHETIC NONAPEPTIDE (B.P.P.9a OR SQ 20,881) WHICH INHIBITS CONVERTING ENZYME
- 13 January 1973
- journal article
- Published by Elsevier BV in The Lancet
- Vol. 301 (7794), 72-74
- https://doi.org/10.1016/s0140-6736(73)90468-6
Abstract
No abstract availableThis publication has 11 references indexed in Scilit:
- Inhibition of Pressor Effects of Angiotensin I and Augmentation of Depressor Effects of Bradykinin by Synthetic PeptidesExperimental Biology and Medicine, 1972
- Inhibition of Angiotensin I-Initiated Hemodynamic Changes in Anesthetized Dogs by a Synthetic NonapeptideExperimental Biology and Medicine, 1972
- Angiotensin-converting enzyme inhibitors from the venom of Bothrops jararaca. Isolation, elucidation of structure, and synthesisBiochemistry, 1971
- Bradykinin potentiating peptide PCA-Lys-Trp-Ala-Pro: An inhibitor of the pulmonary inactivation of Bradykinin and conversion of angiotensin I to IIBiochemical Pharmacology, 1971
- POTENTIAL SCREENING TEST FOR DETECTION OF OVERACTIVITY OF RENIN-ANGIOTENSIN SYSTEMThe Lancet, 1971
- Some Properties of Angiotensin Converting Enzyme in the Lung in vivoNature, 1970
- Activity of Various Fractions of Bradykinin Potentiating Factor against Angiotensin I Converting EnzymeNature, 1970
- Metabolism of the Angiotensins in Isolated Perfused TissuesNature, 1969
- Conversion of Angiotensin I to Angiotensin II by Cell-free Extracts of Dog LungNature, 1968
- A BRADYKININ‐POTENTIATING FACTOR (BPF) PRESENT IN THE VENOM OF BOTHROPS JARARACABritish Journal of Pharmacology and Chemotherapy, 1965